Found 35 matching trials
Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study) PHASE2 The purpose of this study is to see whether combination treatment of Teclis...
Show More Location
University of Miami
Learn More & Join Trial
A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma PHASE3 The purpose of this study is to show that subcutaneous (SC) administration ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation) PHASE4 The DARA-MVI Study is a prospective, randomized, controlled, open-label tri...
Show More Status
Active Not Recruiting
Location
Transplant-nephrology department
Learn More & Join Trial
Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex PHASE3 The purpose of this study is to evaluate the effects of the addition of dar...
Show More Learn More & Join Trial
A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma PHASE1 The purpose of this study is to evaluate the tolerability and safety of sub...
Show More Location
National Hospital Organization Shibukawa Medical Center
Learn More & Join Trial
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA PHASE4 Multiple myeloma (MM) is a neoplastic disease deriving from an abnormal pro...
Show More Status
Active Not Recruiting
Location
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Learn More & Join Trial
Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study NA This is a prospective and single arm clinical study. The goal of this clini...
Show More Location
The First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma PHASE1 This phase I trial studies the possible benefits and side effects of adding...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD PHASE2 This is an open-label, multicenter, Phase 2 study in subjects with newly di...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma PHASE2 The goal of this Phase 2, open-label, multicenter, non-randomized pilot stu...
Show More Status
Active Not Recruiting
Location
Hospital Germans Trials i Pujol
Learn More & Join Trial